BD Epicenter v6.20A (used in conjunction with Bruker MALDI BioTyper) An in vitro diagnostic medical device (IVD) 의 리콜

Recall

RC-2014-RN-00883-1

Class III

2014-08-08

Australia

DHTGA

https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2014-RN-00883-1

Bd epicenter allows for the integration of bd phoenix drug susceptibility results with bruker's maldi biotyper organism identification results within a single id/ast workflow.Bruker updated the maldi biotyper msp database where organism naming changes have been implemented. bd, unaware of these changes, did not implement corresponding changes to the bd epicenter database. this could lead to inconsistency of the orgnaism name between the bd epicenter and bruker maldi biotyper for a limited number of organisms.Bd has performed an analysis of the changes and determined that these inconsistencies either have no relevance to human care (relevant only to plant or animal infection) or have limited impact to human care due to no claims for id or ast in the bd phoenix system.

BD has developed a tool that will update the relevant data to ensure consistency between the MALDI BioTyper and BD EpiCenter systems after a Bruker MSP database change. This tool will be run by a BD Technical Service representative or can be applied through a remote connection. This action has been closed-out on 01/03/2016.